Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer.
Janine ZiemonsRomy AarnoutseAnne HeuftLars E HillegeJanneke WaelenJudith De Vos-GeelenLiselot Valkenburg-van IerselIrene E G van HellemondGeert-Jan M CreemersArnold BaarsJohanna H M J VestjensJohn PendersKoen VenemaMarjolein L SmidtPublished in: Clinical and experimental medicine (2023)
The current study was registered in the Dutch Trial Register (NTR6957) on 17/01/2018 and can be consulted via the International Clinical Trial Registry Platform (ICTRP).